Research into Liver Cancer

Reading time: 1 min

To continue advancing in the treatment of liver cancer, the Hepatic Oncology-BCLC Unit promotes research and innovation projects with a multidisciplinary and patient-centred approach. 

These projects include:

  • The study of the microbiome and its relationship with the response to immunotherapy (by the AECC), which investigates how intestinal bacteria can influence the response to immunotherapy treatments.
  • The identification of new markers for precision medicine (at ISCIII) to advance towards more personalised medical treatment. 

In addition, work is being done on the application of artificial intelligence in radiology, pathological anatomy and clinical decision making. 

All these lines converge in the BCLC.AI program, which aims to combine biological, clinical and imaging data to fully personalise liver cancer treatment.

Substantiated information by:

Alejandro Forner González
Jordi Bruix Tudo
María Reig Monzón
Neus Llarch Alfonso

Published: 13 May 2020
Updated: 13 May 2020

The donations that can be done through this webpage are exclusively for the benefit of Hospital Clínic of Barcelona through Fundació Clínic per a la Recerca Biomèdica and not for BBVA Foundation, entity that collaborates with the project of PortalClínic.

Subscribe

Receive the latest updates related to this content.

Thank you for subscribing!

If this is the first time you subscribe you will receive a confirmation email, check your inbox

An error occurred and we were unable to send your data, please try again later.